OXIS International, Inc. (OXIS) - Financial and Strategic SWOT Analysis Review by GlobalData

VIEWS: 3 PAGES: 38

More Info
									         OXIS International, Inc. (OXIS) - Financial and Strategic SWOT Analysis
                                           Review
        Reference Code: GDPH2235FSA                                                                                           Publication Date: AUG 2012

          2nd Floor, 468 N. Camden Dr.                       Phone              +1 310 8605184                  Revenue          0.0 (million USD)
          Beverly Hills, CA                                  Fax                                                Net Profit       -3.70 (million USD)
          90210                                              Website            www.oxis.com                    Employees        1
                                                                                OXIS     [Over          The                      Pharmaceuticals           &
          United States                                      Exchange                                           Industry
                                                                                Counter]                                         Healthcare

       Company Overview
       Oxis International, Inc. (Oxis) carries out research, development and marketing of products which prevents the harmful effects of
       oxidative stress and inflammation. The company's finished products and finished product candidates include cosmeceutical
       products, therapeutic nutraceutical products, functional foods and functional beverages. Primarily, the company concentrates on
       L-Ergothioneine (ERGO), a product which provides unique amino acid naturally occurring compound as a key component. Oxis
       owns a patented process to synthesize commercial quantities of ERGO. The company operates in North America; Europe, Middle
       East and Africa; Latin America; Asia Pacific and various other countries.
       Key Executives                                                                SWOT Analysis
                      Name                                 Title                      OXIS International, Inc., SWOT Analysis
         David Saloff                        Chairman                                 Strengths                              Weaknesses
         Anshuman Dube                       Director
                                                                                      Ergothioneine Antioxidant              History of Losses
         Thomas W. Hoog                      Director
                                                                                      Focused Research and                   Dependence on Single
         Kenneth Eaton                       Director
                                                                                      Development Activities                 Economy
         Anthony J. Cataldo                  Director
        Source: Annual Report, Company Website, Primary and Secondary
        Research, GlobalData                                                          Opportunities                          Threats

       Share Data                                                                     Aging Population                       Reliance on Third Party
         OXIS International, Inc.                                                                                            Manufacturers
                                                                                      Joint Venture: engage:BDR,
        Share Price (USD) as on 02-Aug-                                  0.02         Inc.                                   Stringent Government
        2012                                                                                                                 Regulations
        EPS (USD)                                                       -0.02
        Market Cap (million USD)                                            9        Source: Annual Report, Company Website, Primary and Secondary Research,
                                                                                     GlobalData
        Enterprise Value (million USD)                                     11
        Shares Outstanding (million)                                     330
       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData

       Financial Performance                                                         Recent Developments
                                                                                      May 21, 2012         OXIS International Reports Q1 2012 Results
                                                                                      Apr 16, 2012         OXIS International Reports 2011 Results
                                                                                      Mar 28, 2012         OXIS Announces Publication Of ERGOFLEX
                                                                                                           Joint Pain Study In Preventive Medicine
                                                                                      Jan 05, 2012         Oxis International Appoints Suzy Couturier As
                                                                                                           Vice President
                                                                                     Source: Annual Report, Company Website, Primary and Secondary Research,
                                                                                     GlobalData



       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData




OXIS International, Inc. (OXIS) - Financial and Strategic SWOT                                                                  Reference Code: GDPH2235FSA
Analysis Review
Source : www.globalcompanyintelligence.com                                                                                                                     Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 4
          List of Figures ................................................................................................................................................................................. 4
       Section 1 - About the Company.......................................................................................................................................................... 5
       OXIS International, Inc. - Key Facts ................................................................................................................................................... 5
       OXIS International, Inc. - Key Employees .......................................................................................................................................... 6
       OXIS International, Inc. - Key Employee Biographies ........................................................................................................................ 7
       OXIS International, Inc. - Major Products and Services ..................................................................................................................... 8
       OXIS International, Inc. - History ........................................................................................................................................................ 9
       OXIS International, Inc. - Company Statement................................................................................................................................. 11
       OXIS International, Inc. - Locations And Subsidiaries ...................................................................................................................... 13
          Head Office ................................................................................................................................................................................... 13
          Other Locations & Subsidiaries ..................................................................................................................................................... 13
       Section 2 – Company Analysis ......................................................................................................................................................... 14
       OXIS International, Inc. - Business Description ................................................................................................................................ 14
       OXIS International, Inc. - Corporate Strategy ................................................................................................................................... 15
       OXIS International, Inc. - SWOT Analysis ........................................................................................................................................ 16
          SWOT Analysis - Overview........................................................................................................................................................... 16
          OXIS International, Inc. - Strengths .............................................................................................................................................. 16
             Strength - Ergothioneine Antioxidant ......................................................................................................................................... 16
             Strength - Focused Research and Development Activities ....................................................................................................... 16
             Strength - Diversified Product Portfolio ..................................................................................................................................... 16
          OXIS International, Inc. - Weaknesses ......................................................................................................................................... 16
             Weakness - History of Losses ................................................................................................................................................... 16
             Weakness - Dependence on Single Economy .......................................................................................................................... 17
          OXIS International, Inc. - Opportunities ........................................................................................................................................ 17
             Opportunity - Aging Population ................................................................................................................................................. 17
             Opportunity - Joint Venture: engage:BDR, Inc. ......................................................................................................................... 17
             Opportunity - Pipeline Products ................................................................................................................................................. 17
          OXIS International, Inc. - Threats ................................................................................................................................................. 17
             Threat - Reliance on Third Party Manufacturers ....................................................................................................................... 17
             Threat - Stringent Government Regulations .............................................................................................................................. 18
             Threat - Competitive Environment ............................................................................................................................................. 18
       OXIS International, Inc. - Key Competitors ....................................................................................................................................... 19
       Section 3 – Company Financial Ratios ............................................................................................................................................. 20
       Financial Ratios - Capital Market Ratios........................................................................................................................................... 20
       Financial Ratios - Annual Ratios ...................................................................................................................................................... 20
       Performance Chart ........................................................................................................................................................................... 22
       Financial Performance...................................................................................................................................................................... 22
       Financial Ratios - Interim Ratios....................................................................................................................................................... 23
       Financial Ratios - Ratio Charts ......................................................................................................................................................... 24
       Section 4 – Company’s Lifesciences Financial Deals and Alliances ................................................................................................ 25
          OXIS International, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012 ....................................................... 25
          OXIS International, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2006 to YTD 2012 ...................................................... 26
          OXIS International, Inc., Medical Equipment, Deals By Year, 2006 to YTD 2012......................................................................... 27


OXIS International, Inc. (OXIS) - Financial and Strategic SWOT                                                                                                   Reference Code: GDPH2235FSA
Analysis Review
Source : www.globalcompanyintelligence.com                                                                                                                                                                Page 2
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or res
								
To top